Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.430
+0.260 (8.20%)
At close: Aug 28, 2026, 4:00 PM EDT
3.300
-0.130 (-3.79%)
After-hours: Aug 28, 2026, 7:38 PM EDT

HCW Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.720.052.572.846.72-
Revenue Growth
707.02%-97.89%-9.68%-57.73%--
Gross Profit
6.450.010.960.562.59-
Operating Income
-6.18-13.66-28.16-25.72-15.08-13.37
Net Income
-21.41-22.3-30.02-24.99-14.9-12.86
Earnings Per Share
-27.18-63.78-185.75-166.96-99.83-164.46
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.741.954.673.632.0636.71
Total Debt
6.566.8113.696.456.6-
Net Cash (Debt)
-5.82-4.86-9.02-2.8625.4636.71
Net Cash Growth
-----30.65%365.41%
Net Cash Per Share
-7.39-13.89-55.79-19.08170.58469.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.14-13.39-14.23-22.51-10.39-10.98
Capital Expenditures
---0.26-6.2-10.28-0.05
Free Cash Flow
-12.14-13.39-14.49-28.72-20.66-11.02
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.91%20.00%37.38%19.72%38.48%-
Operating Margin
-92.02%-25192.71%-1096.95%-904.96%-224.32%-
Pretax Margin
-78.14%-14677.14%-1169.70%-879.52%-221.67%-
Profit Margin
-318.55%-41117.24%-1169.70%-879.52%-221.67%-
FCF Margin
-180.58%-24693.20%-564.48%-1010.51%-307.36%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.9448.357.7415.5110.22-